-
Uncategorized1 month ago
FDA uncertainty persists as search for Prasad successor at CBER drags on
FDA uncertainty persists as search for Prasad successor at CBER drags on
-
Uncategorized1 month ago
Cytokinetics succeeds where Bristol Myers failed in heart muscle disease
Cytokinetics’ pill for a heart muscle disorder called hypertrophic cardiomyopathy could see its addressable market double after it succeeded in a pivotal trial for another form...
-
Uncategorized1 month agoGenomics and Greywolf partner on autoimmune disease treatments
Techbio company Genomics has partnered with biotech company Greywolf Therapeutics to advance novel antigen modulation treatments to treat autoimmune diseases. Under the agreement, Genomics is set to...
-
Uncategorized1 month agoSTAT+: Top lawmaker takes aim at doctor lobby, linking AMA’s billing codes to fraud fight
WASHINGTON — For decades, politicians have blamed the country’s biggest doctor lobby for some of the health care systems problems. Now it faces a new line...
-
Uncategorized1 month ago
Cytospire hauls in $83M for a new type of T cell engager
The British biotechnology startup is making "pan-gamma delta” T cell engagers it says can address the limitations of similar, existing therapies. Read More
-
Uncategorized1 month ago
IPF draws investor heat as biotechs target fibrosis halt, better tolerability
Novel targets aim to stop lung scarring—where current drugs only slow it—while improving tolerability and unlocking fibrosis in other organs next
-
Uncategorized1 month agoSTAT+: Johnson & Johnson advances IBD therapy, despite trial miss
A closely watched therapy developed by Johnson & Johnson failed to show a statistically meaningful improvement for patients with inflammatory bowel disease. But the company plans...
-
Uncategorized1 month ago
Sertraline manufacturer recalls antidepressant batch after UK packaging mix-up
A subsidiary of Indian drugmaker Hetero Group mistakenly packaged two types of antidepressants in packs of sertraline, potentially posing risks to patients.
-
Uncategorized1 month ago
A PIVOT towards single-cell functional genetic screening in plants
Nature Biotechnology, Published online: 05 May 2026; doi:10.1038/s41587-026-03141-0 We developed PIVOT, a single-cell screening platform for functional characterization of plant genes. PIVOT enables delivery of gene...
-
Uncategorized1 month ago
Vertex drops mRNA cystic fibrosis program over ‘tolerability’ issues
Vertex Pharmaceuticals said it has dropped development of an mRNA-based cystic fibrosis therapy, after facing challenges delivering the genetic medicine similar to those that have troubled...
